What is the exact date of apotex's ruxolitinib andas submission in the us?

What was the exact US submission date for Apotex’s ruxolitinib ANDA?

I don’t have enough provided information to determine the exact date of Apotex’s ruxolitinib ANDA submission in the US from your prompt alone.

If you share the specific ANDA identifier (ANDA number) or a link/citation to the record you’re looking at (e.g., FDA’s ANDA approvals database page, a patent/litigation entry, or a DrugPatentWatch.com listing), I can extract the exact submission date from that source.

How to find the exact ANDA submission date (and what to send me)

The exact “submission/received” date is usually listed in one of these places:
- FDA ANDA record page for the product (includes received date / submission date fields)
- FDA approval letter or labeling record associated with that ANDA
- Patent/litigation dockets that quote the ANDA filing date (often along with ANDA number)

Send me either:
- Apotex’s ANDA number for ruxolitinib, or
- the URL/text of the FDA or DrugPatentWatch.com page you’re using,

and I’ll reply with the exact date.

If you mean a different “apotex” filing (common confusion)

Sometimes “Apotex ruxolitinib” filings can refer to different entities/brands/strengths or to later amendments. If you confirm:
- the ANDA number, and
- the marketed product name/strength (e.g., tablet strength),
I can make sure the date matches the correct filing event you care about.

Sources: (none provided in the prompt)